Pfizer/BioNTech’s Updated Omicron Adapted COVID-19 Shot Increases Neutralizing Antibodies Above Pre-Booster Levels
Pfizer IncPFE andBioNTech SEBNTX haveannounced early datafrom a Phase 2/3 trial evaluating the safety, tolerability, and immunogenicity of Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine.
A 30-g booster dose of the Omicron BA.4/BA.5-adapted bivalent vaccine demonstrated a substantial increase in the Omicron BA.4/BA.5 neutralizing antibody response above pre-booster levels, with similar responses seen across individuals aged 18 to 55 years of age and those older than 55 years of age.
FDA and European Medicines Agency approved a 30-g booster dose of the Omicron BA.4/BA.5-adapted vaccine for ages 12 years and older.
Wednesday, the FDA granted Emergency Use Authorization for a 10-g booster dose of Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine inchildren 5-11 years.
A comparison of responses in individuals older than 55 who received the bivalent vaccine or the original vaccine showed that a 30-g booster dose of the Original Pfizer-BioNTech COVID-19 Vaccine elicited more limited increases in the neutralizing antibody response against the Omicron BA.4/BA.5 variants.
The Omicron BA.4/BA.5-adapted bivalent vaccine was well tolerated, with early data indicating a favorable safety profile similar to the original vaccine.
Additional data measuring responses at one-month post-administration of the Omicron BA.4/BA.5 bivalent vaccine booster are expected in the coming weeks.
Additionally, the companies have initiated a similar Phase 1/2/3 trial investigating the Omicron BA.4/BA.5-adapted bivalent vaccine among children six months through 11 years of age.
Price Action: BNTX shares are down 2.19% at $133.66, and PFE stock is down 0.60% at $41.78 during the market session on the last check Thursday.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1233676424-c891b2d7f89446f58b98d3b7d10d2ff3.jpg "Campaign Promises and the Economy")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2076671053-ff0e800c89684fabb96eb46d32650e55.jpg "Why and How Student Loan Creditors Can Garnish Your Money")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-510752465-10cdb9eac0884220ae04232d2950ca87.jpg "This Is the Perfect Place for Your Second Home Abroad—And It Might Not Be Where You Think")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1567505009-09f8705bfdcd40aaa9797052677728ba.jpg "Using the Coppock Curve to Generate Trade Signals")